DEVICE CATEGORY · QJI
Interoperable Automated Glycemic Controller
An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
twiist Loop AlgorithmK262576 | Deka Research and Development Corp. | 510(k) clearance | Oct 15, 2026 | FDA |
iOS CamAPS FXK261896 | CamDiab | 510(k) clearance | Sep 16, 2026 | FDA |
| Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
Source information
Follow the FDA links to view the original records.

